HEADER HYDROLASE 18-AUG-04 1W6H
TITLE NOVEL PLASMEPSIN II-INHIBITOR COMPLEX
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PLASMEPSIN 2;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: ASPARTIC PROTEASE, ASPARTIC HEMOGLOBINASE II, PFAPD;
COMPND 5 EC: 3.4.23.39;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM;
SOURCE 3 ORGANISM_TAXID: 5833;
SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS MALARIA, DRUG, ASPARTIC PROTEASE, PLASMEPSIN, HYDROLASE, GLYCOPROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR J.LINDBERG,P.-O.JOHANSSON,A.ROSENQUIST,I.KVARNSTROEM,L.VRANG,
AUTHOR 2 B.SAMUELSSON,T.UNGE
REVDAT 4 23-OCT-24 1W6H 1 REMARK
REVDAT 3 17-JAN-18 1W6H 1 REMARK
REVDAT 2 24-FEB-09 1W6H 1 VERSN
REVDAT 1 05-JUL-06 1W6H 0
JRNL AUTH J.LINDBERG,P.-O.JOHANSSON,A.ROSENQUIST,I.KVARNSTROEM,
JRNL AUTH 2 L.VRANG,B.SAMUELSSON,T.UNGE
JRNL TITL STRUCTURAL STUDY OF A NOVEL INHIBITOR WITH BULKY P1 SIDE
JRNL TITL 2 CHAIN IN COMPLEX WITH PLASMEPSIN II -IMPLICATIONS FOR DRUG
JRNL TITL 3 DESIGN
JRNL REF TO BE PUBLISHED
JRNL REFN
REMARK 2
REMARK 2 RESOLUTION. 2.24 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.1.24
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.24
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 84.51
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0
REMARK 3 NUMBER OF REFLECTIONS : 25914
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.200
REMARK 3 R VALUE (WORKING SET) : 0.197
REMARK 3 FREE R VALUE : 0.246
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1377
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.24
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.30
REMARK 3 REFLECTION IN BIN (WORKING SET) : 1732
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : 0.2380
REMARK 3 BIN FREE R VALUE SET COUNT : 98
REMARK 3 BIN FREE R VALUE : 0.3020
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 5148
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 92
REMARK 3 SOLVENT ATOMS : 230
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.27
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 2.61000
REMARK 3 B22 (A**2) : -2.41000
REMARK 3 B33 (A**2) : -0.20000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : -0.12000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.546
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.259
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.183
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.347
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5446 ; 0.016 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): 4808 ; 0.002 ; 0.020
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7412 ; 1.582 ; 1.972
REMARK 3 BOND ANGLES OTHERS (DEGREES): 11272 ; 1.142 ; 3.000
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 656 ; 7.165 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 850 ; 0.148 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5992 ; 0.006 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): 1074 ; 0.003 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1041 ; 0.211 ; 0.200
REMARK 3 NON-BONDED CONTACTS OTHERS (A): 5670 ; 0.241 ; 0.200
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): 3248 ; 0.091 ; 0.200
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 255 ; 0.175 ; 0.200
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 34 ; 0.149 ; 0.200
REMARK 3 SYMMETRY VDW OTHERS (A): 127 ; 0.212 ; 0.200
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 18 ; 0.118 ; 0.200
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3272 ; 0.952 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5330 ; 1.749 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2174 ; 2.118 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2082 ; 3.423 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : BABINET MODEL WITH MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.40
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS.
REMARK 4
REMARK 4 1W6H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-AUG-04.
REMARK 100 THE DEPOSITION ID IS D_1290020816.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : NULL
REMARK 200 TEMPERATURE (KELVIN) : 100.0
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : MAX II
REMARK 200 BEAMLINE : I711
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.13375
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : NULL
REMARK 200 DETECTOR MANUFACTURER : NULL
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL
REMARK 200 DATA SCALING SOFTWARE : NULL
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25914
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200
REMARK 200 RESOLUTION RANGE LOW (A) : 85.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0
REMARK 200 DATA REDUNDANCY : 2.000
REMARK 200 R MERGE (I) : 0.07000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: NULL
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 36.81
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.80700
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PQS
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PQS
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400
REMARK 400 COMPOUND
REMARK 400 CATALYTIC ACTIVITY: HYDROLYSIS OF THE BONDS LINKING
REMARK 400 CERTAIN HYDROPHOBIC RESIDUES IN HEMOGLOBIN OR GLOBIN.
REMARK 400 ALSO CLEAVES SMALL MOLECULES SUBSTRATES SUCH AS
REMARK 400 ALA-LEU-GLU-ARG-THR-PHE-|-PHE(NO(2))-SER-PHE-PRO-THR.
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 LEU A -1
REMARK 465 GLY A 0
REMARK 465 PRO A 240
REMARK 465 PHE A 241
REMARK 465 LEU A 242
REMARK 465 PRO A 243
REMARK 465 LEU B -1
REMARK 465 GLY B 0
REMARK 465 PRO B 240
REMARK 465 PHE B 241
REMARK 465 LEU B 242
REMARK 465 PRO B 243
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ASP A 225 CB - CG - OD2 ANGL. DEV. = 6.3 DEGREES
REMARK 500 ASP A 303 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES
REMARK 500 ASP A 316 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES
REMARK 500 ASP B 19 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES
REMARK 500 ASP B 137 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES
REMARK 500 ASP B 225 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES
REMARK 500 ASP B 279 CB - CG - OD2 ANGL. DEV. = 6.5 DEGREES
REMARK 500 ASP B 303 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP A 69 -73.52 -142.57
REMARK 500 LEU A 126 21.77 -146.62
REMARK 500 LYS A 163 -54.83 -128.70
REMARK 500 LEU A 191 -84.13 -141.88
REMARK 500 VAL A 201 -69.07 -104.67
REMARK 500 ASN A 251 107.07 -49.54
REMARK 500 ASN A 263 31.04 -153.79
REMARK 500 PRO A 282 -73.36 -56.56
REMARK 500 ASN A 288 45.55 -93.29
REMARK 500 ASN B 13 30.23 72.93
REMARK 500 ILE B 14 -51.02 -136.54
REMARK 500 ASP B 69 -66.11 -147.81
REMARK 500 LEU B 126 18.78 -143.40
REMARK 500 LEU B 191 -81.86 -135.11
REMARK 500 LYS B 238 59.79 -91.91
REMARK 500 ILE B 277 32.91 -145.61
REMARK 500 ASN B 288 46.22 -93.27
REMARK 500 ASN B 328 100.39 -172.95
REMARK 500
REMARK 500 REMARK: NULL
REMARK 700
REMARK 700 SHEET
REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN
REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW,
REMARK 700 TWO SHEETS ARE DEFINED.
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TIT A1330
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TIT B1330
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1J8J RELATED DB: PDB
REMARK 900 A NEW CLASS OF SMALL NON-PEPTIDYL COMPOUNDS BLOCKSPLASMODIUM
REMARK 900 FALCIPARUM DEVELOPMENT IN VITRO BY INHIBITINGPLASMEPSINS
REMARK 900 RELATED ID: 1LEE RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF PLASMEPSIN FROM P. FALCIPARUM INCOMPLEX WITH
REMARK 900 INHIBITOR RS367
REMARK 900 RELATED ID: 1LF2 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM INCOMPLEX WITH
REMARK 900 INHIBITOR RS370
REMARK 900 RELATED ID: 1LF3 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM INCOMPLEX WITH
REMARK 900 INHIBITOR EH58
REMARK 900 RELATED ID: 1LF4 RELATED DB: PDB
REMARK 900 STRUCTURE OF PLASMEPSIN II
REMARK 900 RELATED ID: 1M43 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF PMII IN COMPLEX WITH PEPSTATIN A TO2.4 A
REMARK 900 RELATED ID: 1ME6 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF PLASMEPSIN II, AN ASPARTYL PROTEASEFROM
REMARK 900 PLASMODIUM FALCIPARUM, IN COMPLEX WITH A STATINE-BASED INHIBITOR
REMARK 900 RELATED ID: 1PFZ RELATED DB: PDB
REMARK 900 PROPLASMEPSIN II FROM PLASMODIUM FALCIPARUM
REMARK 900 RELATED ID: 1SME RELATED DB: PDB
REMARK 900 PLASMEPSIN II, A HEMOGLOBIN-DEGRADING ENZYME FROM PLASMODIUM
REMARK 900 FALCIPARUM, IN COMPLEX WITH PEPSTATIN A
REMARK 900 RELATED ID: 1W6I RELATED DB: PDB
REMARK 900 PLASMEPSIN II-PEPSTATIN A COMPLEX
REMARK 900 RELATED ID: 1XDH RELATED DB: PDB
REMARK 900 STRUCTURE OF PLASMEPSIN II IN COMPLEX WITH PEPSTATIN A
REMARK 900 RELATED ID: 1XE5 RELATED DB: PDB
REMARK 900 STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATINANALOGUE
REMARK 900 RELATED ID: 1XE6 RELATED DB: PDB
REMARK 900 STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATINANALOGUE
REMARK 900 RELATED ID: 2BJU RELATED DB: PDB
REMARK 900 PLASMEPSIN II COMPLEXED WITH A HIGHLY ACTIVE ACHIRAL INHIBITOR
REMARK 900 RELATED ID: 2BL3 RELATED DB: PDB
REMARK 900 THEORITICAL INTERACTION MODEL OF PLASMEPSIN II FROM PLASMODIUM
REMARK 900 FALCIPARUM WITH A LIGAND FROM AN ECODED STATIN COMBINATORIAL LIBRARY
DBREF 1W6H A -1 329 UNP P46925 PLM2_PLAFA 123 453
DBREF 1W6H B -1 329 UNP P46925 PLM2_PLAFA 123 453
SEQRES 1 A 331 LEU GLY SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE
SEQRES 2 A 331 GLN ASN ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP
SEQRES 3 A 331 ASN GLN GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER
SEQRES 4 A 331 ALA ASN LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA
SEQRES 5 A 331 GLY CYS LEU THR LYS HIS LEU TYR ASP SER SER LYS SER
SEQRES 6 A 331 ARG THR TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN
SEQRES 7 A 331 TYR VAL SER GLY THR VAL SER GLY PHE PHE SER LYS ASP
SEQRES 8 A 331 LEU VAL THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE
SEQRES 9 A 331 ILE GLU VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR
SEQRES 10 A 331 THR ALA SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP
SEQRES 11 A 331 LYS ASP LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL
SEQRES 12 A 331 GLU LEU LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE
SEQRES 13 A 331 THR PHE TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE
SEQRES 14 A 331 LEU THR ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY
SEQRES 15 A 331 PRO LEU THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP
SEQRES 16 A 331 GLN ILE THR LEU ASP ALA HIS VAL GLY ASN ILE MET LEU
SEQRES 17 A 331 GLU LYS ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA
SEQRES 18 A 331 ILE THR VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN
SEQRES 19 A 331 ASN LEU ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR
SEQRES 20 A 331 VAL THR LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU
SEQRES 21 A 331 PHE THR SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU
SEQRES 22 A 331 TYR TYR LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU
SEQRES 23 A 331 CYS MET LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO
SEQRES 24 A 331 THR PHE ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE
SEQRES 25 A 331 THR VAL PHE ASP TYR ASP ASN HIS SER VAL GLY ILE ALA
SEQRES 26 A 331 LEU ALA LYS LYS ASN LEU
SEQRES 1 B 331 LEU GLY SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE
SEQRES 2 B 331 GLN ASN ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP
SEQRES 3 B 331 ASN GLN GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER
SEQRES 4 B 331 ALA ASN LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA
SEQRES 5 B 331 GLY CYS LEU THR LYS HIS LEU TYR ASP SER SER LYS SER
SEQRES 6 B 331 ARG THR TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN
SEQRES 7 B 331 TYR VAL SER GLY THR VAL SER GLY PHE PHE SER LYS ASP
SEQRES 8 B 331 LEU VAL THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE
SEQRES 9 B 331 ILE GLU VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR
SEQRES 10 B 331 THR ALA SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP
SEQRES 11 B 331 LYS ASP LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL
SEQRES 12 B 331 GLU LEU LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE
SEQRES 13 B 331 THR PHE TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE
SEQRES 14 B 331 LEU THR ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY
SEQRES 15 B 331 PRO LEU THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP
SEQRES 16 B 331 GLN ILE THR LEU ASP ALA HIS VAL GLY ASN ILE MET LEU
SEQRES 17 B 331 GLU LYS ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA
SEQRES 18 B 331 ILE THR VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN
SEQRES 19 B 331 ASN LEU ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR
SEQRES 20 B 331 VAL THR LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU
SEQRES 21 B 331 PHE THR SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU
SEQRES 22 B 331 TYR TYR LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU
SEQRES 23 B 331 CYS MET LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO
SEQRES 24 B 331 THR PHE ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE
SEQRES 25 B 331 THR VAL PHE ASP TYR ASP ASN HIS SER VAL GLY ILE ALA
SEQRES 26 B 331 LEU ALA LYS LYS ASN LEU
HET TIT A1330 46
HET TIT B1330 46
HETNAM TIT N-((3S,4S)-5-[(4-BROMOBENZYL)OXY]-3-HYDROXY-4-{[N-
HETNAM 2 TIT (PYRIDIN-2-YLCARBONYL)-L-VALYL]AMINO}PENTANOYL)-L-
HETNAM 3 TIT ALANYL-L-LEUCINAMIDE
FORMUL 3 TIT 2(C32 H45 BR N6 O7)
FORMUL 5 HOH *230(H2 O)
HELIX 1 1 THR A 49 LYS A 55 5 7
HELIX 2 2 ASP A 59 SER A 63 5 5
HELIX 3 3 THR A 108 GLU A 112 5 5
HELIX 4 4 PRO A 113 SER A 118 1 6
HELIX 5 5 TRP A 128 SER A 132 5 5
HELIX 6 6 PRO A 138 GLN A 146 1 9
HELIX 7 7 GLU A 174 ARG A 176 5 3
HELIX 8 8 PRO A 223 GLN A 232 1 10
HELIX 9 9 GLU A 269 TYR A 273 1 5
HELIX 10 10 GLY A 302 LYS A 308 1 7
HELIX 11 11 THR B 49 LYS B 55 5 7
HELIX 12 12 ASP B 59 SER B 63 5 5
HELIX 13 13 THR B 108 GLU B 112 5 5
HELIX 14 14 PRO B 113 SER B 118 1 6
HELIX 15 15 TRP B 128 SER B 132 5 5
HELIX 16 16 PRO B 138 GLN B 146 1 9
HELIX 17 17 GLU B 174 ARG B 176 5 3
HELIX 18 18 PRO B 223 GLN B 232 1 10
HELIX 19 19 GLU B 269 TYR B 273 1 5
HELIX 20 20 GLY B 302 LYS B 308 1 7
SHEET 1 AA 3 LYS A 72 TYR A 77 0
SHEET 2 AA 3 GLY A 80 VAL A 93 -1 O GLY A 80 N TYR A 77
SHEET 3 AA 3 MET A 15 VAL A 22 -1 O GLU A 21 N THR A 92
SHEET 1 AB 7 LYS A 72 TYR A 77 0
SHEET 2 AB 7 GLY A 80 VAL A 93 -1 O GLY A 80 N TYR A 77
SHEET 3 AB 7 LEU A 96 ASP A 107 -1 O LEU A 96 N VAL A 93
SHEET 4 AB 7 LEU A 40 PRO A 43 1 O LEU A 40 N ILE A 103
SHEET 5 AB 7 GLY A 122 GLY A 125 -1 O ILE A 123 N TRP A 41
SHEET 6 AB 7 GLN A 27 ASP A 34 1 O ILE A 32 N LEU A 124
SHEET 7 AB 7 MET A 15 VAL A 22 -1 O GLY A 18 N PHE A 31
SHEET 1 AC 4 ILE A 237 LYS A 238 0
SHEET 2 AC 4 TYR A 245 LEU A 248 -1 O VAL A 246 N ILE A 237
SHEET 3 AC 4 LEU A 284 LEU A 287 -1 O CYS A 285 N THR A 247
SHEET 4 AC 4 LEU A 274 HIS A 276 -1 O GLN A 275 N MET A 286
SHEET 1 BA 3 LYS B 72 TYR B 77 0
SHEET 2 BA 3 GLY B 80 VAL B 93 -1 O GLY B 80 N TYR B 77
SHEET 3 BA 3 MET B 15 VAL B 22 -1 O GLU B 21 N THR B 92
SHEET 1 BB 7 LYS B 72 TYR B 77 0
SHEET 2 BB 7 GLY B 80 VAL B 93 -1 O GLY B 80 N TYR B 77
SHEET 3 BB 7 LEU B 96 ASP B 107 -1 O LEU B 96 N VAL B 93
SHEET 4 BB 7 LEU B 40 PRO B 43 1 O LEU B 40 N ILE B 103
SHEET 5 BB 7 GLY B 122 GLY B 125 -1 O ILE B 123 N TRP B 41
SHEET 6 BB 7 GLN B 27 ASP B 34 1 O ILE B 32 N LEU B 124
SHEET 7 BB 7 MET B 15 VAL B 22 -1 O GLY B 18 N PHE B 31
SHEET 1 BC 7 LYS B 265 LEU B 268 0
SHEET 2 BC 7 PHE B 257 THR B 260 -1 O PHE B 257 N LEU B 268
SHEET 3 BC 7 GLN B 194 HIS B 200 -1 O ASP B 198 N THR B 260
SHEET 4 BC 7 MET B 205 VAL B 213 -1 O LEU B 206 N ALA B 199
SHEET 5 BC 7 THR B 298 LEU B 301 1 O PHE B 299 N ILE B 212
SHEET 6 BC 7 ILE B 220 VAL B 222 -1 O THR B 221 N ILE B 300
SHEET 7 BC 7 ILE B 289 GLY B 291 1 O ILE B 290 N VAL B 222
SHEET 1 BD 4 VAL B 236 ILE B 237 0
SHEET 2 BD 4 VAL B 246 LEU B 248 -1 O VAL B 246 N ILE B 237
SHEET 3 BD 4 LEU B 284 LEU B 287 -1 O CYS B 285 N THR B 247
SHEET 4 BD 4 LEU B 274 HIS B 276 -1 O GLN B 275 N MET B 286
SSBOND 1 CYS A 47 CYS A 52 1555 1555 2.06
SSBOND 2 CYS A 249 CYS A 285 1555 1555 2.04
SSBOND 3 CYS B 47 CYS B 52 1555 1555 2.07
SSBOND 4 CYS B 249 CYS B 285 1555 1555 2.05
CISPEP 1 GLU A 112 PRO A 113 0 1.69
CISPEP 2 GLU B 112 PRO B 113 0 0.34
SITE 1 AC1 16 ILE A 32 ASP A 34 GLY A 36 SER A 37
SITE 2 AC1 16 ASN A 76 TYR A 77 VAL A 78 SER A 79
SITE 3 AC1 16 PHE A 111 THR A 114 PHE A 120 TYR A 192
SITE 4 AC1 16 ASP A 214 GLY A 216 THR A 217 SER A 218
SITE 1 AC2 14 ASP B 34 GLY B 36 SER B 37 ASN B 76
SITE 2 AC2 14 TYR B 77 VAL B 78 SER B 79 PHE B 111
SITE 3 AC2 14 THR B 114 TYR B 192 ASP B 214 GLY B 216
SITE 4 AC2 14 THR B 217 SER B 218
CRYST1 44.210 77.614 84.237 90.00 90.00 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.022619 0.000000 0.000000 0.00000
SCALE2 0.000000 0.012884 0.000000 0.00000
SCALE3 0.000000 0.000000 0.011871 0.00000